Historical Valuation
Charles River Laboratories International Inc (CRL) is now in the Fair zone, suggesting that its current forward PE ratio of 19.20 is considered Fairly compared with the five-year average of 22.42. The fair price of Charles River Laboratories International Inc (CRL) is between 186.01 to 309.72 according to relative valuation methord.
Relative Value
Fair Zone
186.01-309.72
Current Price：220.91
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Charles River Laboratories International Inc (CRL) has a current Price-to-Book (P/B) ratio of 2.93. Compared to its 3-year average P/B ratio of 2.91 , the current P/B ratio is approximately 0.50% higher. Relative to its 5-year average P/B ratio of 4.28, the current P/B ratio is about -31.66% higher. Charles River Laboratories International Inc (CRL) has a Forward Free Cash Flow (FCF) yield of approximately 5.46%. Compared to its 3-year average FCF yield of 4.69%, the current FCF yield is approximately 16.37% lower. Relative to its 5-year average FCF yield of 3.93% , the current FCF yield is about 38.74% lower.
P/B
Median3y
2.91
Median5y
4.28
FCF Yield
Median3y
4.69
Median5y
3.93
Competitors Valuation Multiple
AI Analysis for CRL
The average P/S ratio for CRL competitors is 1.63, providing a benchmark for relative valuation. Charles River Laboratories International Inc Corp (CRL.N) exhibits a P/S ratio of 2.47, which is 51.07% above the industry average. Given its robust revenue growth of -0.49%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CRL
1Y
3Y
5Y
Market capitalization of CRL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CRL in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CRL currently overvalued or undervalued?
Charles River Laboratories International Inc (CRL) is now in the Fair zone, suggesting that its current forward PE ratio of 19.20 is considered Fairly compared with the five-year average of 22.42. The fair price of Charles River Laboratories International Inc (CRL) is between 186.01 to 309.72 according to relative valuation methord.
What is Charles River Laboratories International Inc (CRL) fair value?
CRL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Charles River Laboratories International Inc (CRL) is between 186.01 to 309.72 according to relative valuation methord.
How does CRL's valuation metrics compare to the industry average?
The average P/S ratio for CRL's competitors is 1.63, providing a benchmark for relative valuation. Charles River Laboratories International Inc Corp (CRL) exhibits a P/S ratio of 2.47, which is 51.07% above the industry average. Given its robust revenue growth of -0.49%, this premium appears unsustainable.
What is the current P/B ratio for Charles River Laboratories International Inc (CRL) as of Jan 10 2026?
As of Jan 10 2026, Charles River Laboratories International Inc (CRL) has a P/B ratio of 2.93. This indicates that the market values CRL at 2.93 times its book value.
What is the current FCF Yield for Charles River Laboratories International Inc (CRL) as of Jan 10 2026?
As of Jan 10 2026, Charles River Laboratories International Inc (CRL) has a FCF Yield of 5.46%. This means that for every dollar of Charles River Laboratories International Inc’s market capitalization, the company generates 5.46 cents in free cash flow.
What is the current Forward P/E ratio for Charles River Laboratories International Inc (CRL) as of Jan 10 2026?
As of Jan 10 2026, Charles River Laboratories International Inc (CRL) has a Forward P/E ratio of 19.20. This means the market is willing to pay $19.20 for every dollar of Charles River Laboratories International Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Charles River Laboratories International Inc (CRL) as of Jan 10 2026?
As of Jan 10 2026, Charles River Laboratories International Inc (CRL) has a Forward P/S ratio of 2.47. This means the market is valuing CRL at $2.47 for every dollar of expected revenue over the next 12 months.